ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1284

Idiopathic Inflammatory Myopathies: Are Muscle Biopsies Still Needed?

Belén Virasoro1, Ramiro Gomez 2, Andrea Braillard Poccard 3, Dafne Capelusnik 4, Emilce Schneeberger 5, Silvia Papasidero 6, Juan Bande 6, Malena Viola 7, Maria de la Vega 8, Carolina Costi 9, Mercedes Garcia 10, Cecilia Asnal 11, Ana Cappuccio 12, Demelza Yucra 13, Linda Vergel Orduz 14, Natalia Tamborenea 15, Mariano Rivero 16, Amelia Granel 17, Carolina Segura Escobar 16, Marina Dalpiaz 15 and Cecilia Pisoni 18, 1CEMIC, buenos aires, Buenos Aires, Argentina, 2Hospital de Clínicas José de San Martín, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 3Hospital de Clínicas José de San Martin, Buenos Aires, Buenos Aires, Argentina, 4Instituto de Rehabilitacion Psicofisica, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 5Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 6Hospital General de Agudos Dr. E. Tornú, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 7Hospital Argerich, Argentina, Buenos Aires, Argentina, 8CEIM Investigaciones Medicas, Buenos Aires, Argentina, 9Hospital General “San Martín” de la Plata, La Plata, Buenos Aires, Argentina, 10Hospital San Martín, La Plata, Argentina, 11Instituto Centenario, Buenos Aires, Buenos Aires, Argentina, 12Hospital Francés, Buenos Aires, Buenos Aires, Argentina, 13Sanatorio Güemes, Buenos Aires, Buenos Aires, Argentina, 14Sanatorio Gúemes, Buenos Aires, Buenos Aires, Argentina, 15Hospital Rivadavia, Buenos Aires, Buenos Aires, Argentina, 16Hospital Británico, Buenos Aires, Buenos Aires, Argentina, 17Hospital San Roque,Gonnet,La Plata,Buenos Aires.Argentina, La Plata, Buenos Aires, Argentina, 18Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: biopsies and classification criteria, Idiopathic Inflammatory Myopathies (IIM)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Muscle Biology, Myositis & Myopathies Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Inflammatory myopathies (IM) are a heterogeneous group of diseases characterized by muscle inflammation. In Argentina, there are few pathologists specialized in muscle biopsies and for this reason, there are limitations to perform good quality biopsies.

The objectives of this study are to estimate the frequency of muscle biopsy in patients with IM belonging to Argentinean Society of Rheumatology database, identify the variables associated with its performance and to apply the new EULAR-ACR criteria to the subgroup of patients with biopsy.

Methods: 179 patients with IM were included. Demographic, clinical, laboratory, images and treatment characteristics were collected from medical records.

The muscle biopsy information was obtained from the pathology report of each participating hospital. Therefore, there was no standardization in the report.

To analyze differences between the groups, Chi square was performed for categorical variables and T test or Mann Whitney for continuous variables according to their distribution. Logistic regression analysis was performed for the analysis of variables associated with performing a muscle biopsy.

Results: Table 1 describes clinical characteristics of the cohort. The frequency of muscle biopsies in the cohort was 58 (32%). Table 2 shows variables associated to not having muscle biopsy performed. 

In the logistic regression analysis, the presence of positive antibodies OR 0.21 (CI 95% 0.05- 0.99) and heliotrope rash 0.11 (CI 95% 0.02 to 0.75) were independently associated with NOT performing biopsy.

The complete biopsy report was available in 37 of 52 patients who undergone biopsy. In those patients we applied the EULAR-ACR criteria for inflammatory myopathies with and without biopsy(1).

Conclusion: Muscle biopsy was performed in only one third of patients with IM from our cohort. Patients with myositis-specific antibodies and heliotrope rash were biopsied less frequently. If criteria without biopsy are applied to patients with biopsy most of them will fulfill criteria. Given the difficulties to obtain a good quality muscle biopsy, we propose to only perform muscle biopsy to those patients who do not fulfill non biopsy EULAR-ACR criteria.

References:

  1. Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M De, et al. 2017 European League Against Rheumatism / American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;69(12):2271–82.

Table 1. Clinical characteristics of the cohort.

Table 2. Variables associated to not having muscle biopsy performed.


Disclosure: B. Virasoro, None; R. Gomez, None; A. Braillard Poccard, None; D. Capelusnik, None; E. Schneeberger, None; S. Papasidero, None; J. Bande, None; M. Viola, None; M. de la Vega, AbbVie, 8, BMS, 8, Janssen, 8, Lilly, 8, Pfizer, 5, 8, Raffo, 5, 8, Roche, 9, Sanofi, 5, 8; C. Costi, None; M. Garcia, None; C. Asnal, None; A. Cappuccio, None; D. Yucra, None; L. Vergel Orduz, None; N. Tamborenea, None; M. Rivero, None; A. Granel, None; C. Segura Escobar, None; M. Dalpiaz, None; C. Pisoni, None.

To cite this abstract in AMA style:

Virasoro B, Gomez R, Braillard Poccard A, Capelusnik D, Schneeberger E, Papasidero S, Bande J, Viola M, de la Vega M, Costi C, Garcia M, Asnal C, Cappuccio A, Yucra D, Vergel Orduz L, Tamborenea N, Rivero M, Granel A, Segura Escobar C, Dalpiaz M, Pisoni C. Idiopathic Inflammatory Myopathies: Are Muscle Biopsies Still Needed? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/idiopathic-inflammatory-myopathies-are-muscle-biopsies-still-needed/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/idiopathic-inflammatory-myopathies-are-muscle-biopsies-still-needed/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology